New England Compounding Center, the pharmacy accused of distributing tainted steroids that have killed 39 people and afflicted hundreds more nationwide with meningitis, filed for bankruptcy on Friday.
The filing was expected, because the Framingham-based compounding pharmacy faces heavy litigation costs in personal injury lawsuits from around the country. Compounding Center officials hope to set up a fund in the bankruptcy process to pay victims with claims against the pharmacy, the company said Friday.
“We recognize the need to compensate those affected by the meningitis outbreak fairly and appropriately,” said Keith D. Lowey, who was named chief restructuring officer in the bankruptcy, in the company’s statement.
According to the Centers for Disease Control and Prevention’s latest figures, there have been 367 cases of meningitis, among a total of 620 fungal infections, tied to the outbreak, which began in September. The cases span 19 states, including New Hampshire. The highest case count is 223, in Michigan, according to the CDC.
Fredric Ellis, a Boston attorney who is representing several people from Michigan with claims, said the Chapter 11 filing will stay any litigation against New England Compounding.
You have reached the limit of 5 free articles in a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than 25¢ a week